N30 (Nivalis ) Pharmaceuticals

Startup Venture

Unicircles Rank: 1 | Founded in 2007

Nivalis/ N30Pharma is developing a novel class of disease modifying therapies

Biotech & Health Startups

Community Valuation

Undervalued (1 vote undervalued, 0 votes overvalued)

Unicircles Rating:

Sector:

Biotech / Health Care

Growth Stage:

Not provided

Nearest Metro Area:

Denver

Anonymous

Alumni

INVESTORS

60% Deerfield Management

75% Rock Springs Capital

90% RA Capital Management

90% Wellington Management

YOU MIGHT ALSO LIKE

85% Moderna Therapeutics

85% Voyager Therapeutics

85% Syros Pharmaceuticals

85% NinePoint Medical

85% Loxo Oncology